From a New York Times online article:
For new patients, whose visits entail more work than those of established patients, facility fees typically range from $131 to $322 per visit; for established patients, they are slightly lower. In surgical centers and free-standing emergency rooms, the facility fee can be thousands of dollars.
A facility fee is an additional charge that some medical practices can add to the cost of each doctor visit. The additional charge usually comes as a surprise because, unlike an exam or a test or treatment, the facility fee is not tied directly to hands-on care.
The purpose of the facility fee is to compensate hospitals for the expense of maintaining the physical premises. Hospital-owned, off-campus medical practices are also allowed to charge the facility fee to cover specific regulatory requirements, such as building codes, disaster preparedness, equipment redundancy and other items that are largely invisible to patients.
To read more: https://www.nytimes.com/2019/11/01/well/live/why-was-my-doctor-visit-suddenly-so-expensive.html
The plot line of The Farewell is familiar to me. Like Billi’s Nai Nai, my aunt was diagnosed with metatastic lung cancer. Nobody in the family told her – nor did the doctors when she later underwent surgery to remove a tumour. The last time I saw her was in north-eastern China a few years ago. Her once-plump figure had shrunk to a wiry frame. She was in her early 70s, in good spirits, but a far cry from the feisty matriarch who used to dominate conversations.
The tool is simply called Preventive Health, and is now available to Facebook users in the United States. It takes a user’s age and sex from their Facebook profile and provides them with a list of recommended screenings based on those two data points.
LSE developed the survey to target four key groups:
In the survey analysis we highlight the behavioural element first, giving prominence to the voices and experiences of people living with dementia as direct assessment of actual behaviour is central to discrimination and is the closest representation of the true impact of stigma on people living with dementia.
The current study points to the role of norepinephrine, a neurotransmitter that signals arousal and stress in the central nervous system. This chemical is present in low levels in the brain while we sleep, but when production ramps up it arouses our nerve cells, causing us to wake up and become alert. The study showed that norepinephrine also acts on a specific receptor, the beta2 adrenergic receptor, which is expressed at high levels in microglia. When this chemical is present in the brain, the microglia slip into a sort of hibernation.
The prototype revealed that using artificial intelligence and machine learning to examine certain combinations of vital signs and other biomarkers could strongly 
“The risk for dementia is elevated about twofold in people who have diabetes or 
PayScale reports real-time salary data from over 54 million reports from job seekers, fact checking the data against private and public compensation data.
Boomers Daily 